Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Aurobindo Pharma

Sector: Healthcare | Industry: Drugs & Pharma
R 636.60 7.35  | 1.17% -20.41% 14.68 37,347.73
NSE Price: Sep 16, 15:58 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Sep 16, 15:58 636.60 7.35 1.17% 628.00 629.25 2,113,886 626.15 - 639.30
BSE Sep 16, 2019 636.75 7.00 1.11% 633.00 629.75 76,386 626.00 - 639.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 2,824,856 P/B: 2.57 NSE Code: AUROPHARMA
52-Week Range: R 536.60 - 838.00 Dividend Yield: 0.39% BSE Code: 524804
TTM EPS: R 43.43 Book Value: R 247.84 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Sun Pharmaceutical Inds. (NSE)
  • S&P BSE 100


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 37 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Aurobindo Pharma -14.15 4.39 -1.23 -18.64 -7.00 7.02 24.48
S&P BSE Sensex 3.65 1.15 -5.93 -0.88 9.65 6.67 8.67
S&P BSE Healthcare -6.47 3.54 0.11 -18.26 -7.19 -1.15 12.71
Company's return has been calculated on basis of NSE's price.
As on Sep 13, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 18.83 12.35 19.29
Net Profit -2.40 5.31 15.10
EPS -2.41 5.26 14.94
Book Value 18.92 23.95 29.81
Average
Operating Margin 20.99 22.78 22.97
Net Margin 11.98 13.96 13.83
Return on Networth 18.47 23.01 27.36
Return on Investment 17.97 21.87 24.03
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 2.88 28.10 2.88
Operating Profit 6.65 53.97 6.65
Net Profit 7.72 38.62 7.72
EPS 8.62 39.54 8.62
TTM
Revenue 6.10 21.59 6.10
Operating Profit 10.17 17.02 10.17
Net Profit 7.44 7.62 7.44
EPS 7.62 7.82 7.62
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Aurobindo Pharma 37,347.73 20,757.87 2,537.55 12.14 18.47 2.57 14.68
Divi's Laboratories 43,682.85 5,024.27 1,333.84 25.59 21.00 6.03 32.75
Sun Pharmaceutical Inds. 102,367.63 30,216.10 3,576.65 11.42 8.05 2.39 33.60
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Aug 29, 2019 Nagaraju Ravula  Sell Market 2,626 591.10 15.52
Aug 13, 2019 Ravoori Lakshmi Narasimhaswamy  Sell Market 2,560 602.80 15.43
Jun 18, 2019 Rama Srinivas K  Sell Market 2,500 622.25 15.56
Jun 12, 2019 Sreenivasa Reddy Bhumireddy  Sell Market 2,382 641.55 15.28
Jun 06, 2019 A KARTHIKEYA PRABHU  Sell Market 2,450 624.55 15.30
Fund Houses invested in the stock
Fund Jun-19 Mar-19 Dec-18 Sep-18 Jun-18
HDFC Mutual Fund 6.780 6.070 5.985 6.100 5.976
SBI Mutual Fund 1.592 1.665 1.558 1.356 0.773
Reliance Mutual Fund 1.327 1.581 1.876 1.996 2.265
Aditya Birla Sun Life Mutual Fund 0.752 0.838 0.869 1.363 2.731
IDFC Mutual Fund 0.526 0.764 0.667 0.536 0.462
ICICI Prudential Mutual Fund 0.434 0.461 0.517 0.553 0.591
UTI Mutual Fund 0.271 0.278 0.406 0.443 0.518
Mirae Asset Mutual Fund 0.247 0.279 0.256 0.228 0.242
DSP Mutual Fund 0.172 0.384 0.325 0.264 0.182
Kotak Mahindra Mutual Fund 0.161 0.225 0.469 0.584 0.519
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Aurobindo Pharma Ltd.

Address: Plot No. 2, Maitrivihar, Ameerpet, Hyderabad, Telangana - 500038 | Phone: +91-040-66725000 | Fax: +91-040-23746833 / 23741080

Email: [email protected]

Website: www.aurobindo.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
3.91
Piotroski F-Score
3
Modified C-Score
2
5-Years Price to Earnings
14.50
5-Years Price to Book
2.54
Earnings Yield
EBIT / Enterprise value
8.49%
PEG
Price / Earnings to growth ratio
1.43
Related Stocks
  Current Price   Chng %
Alkem Laboratories R1,859.80 +1.10%
Biocon R230.85 -0.77%
Cadila Healthcare R242.30 +0.17%
Cipla R470.50 +0.32%
Divi's Laboratories R1,644.80 +1.01%
Dr. Reddy's Lab R2,725.30 -0.23%
Lupin R769.15 +0.66%
Piramal Enterprises R1,900.30 -0.17%
Sun Pharmaceutical Inds. R426.80 +0.93%
Torrent Pharmaceuticals R1,709.65 -0.67%
As on Sep 16, 15:59